Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising ...

The first ever avian influenza vaccine recently started trials in the US. This marks a milestone in the prevention of bird ...

For adults aged 50 years or older, an investigational mRNA-based vaccine is superior to standard-dose vaccines for preventing influenza.

The Street-high price target of $38 suggests it could nearly triple from here over the next 12 months. 3M stock also emerges ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near ...

A new mRNA flu vaccine, singing mice and doctors find what may be behind restless leg syndrome. Here are your health ...

"In 2020 — after three years of immunosuppression — when I learned of mRNA vaccine research for MS, I was relieved," writes ...

Moderna confirmed on Friday that it has been pursuing early-stage research into mRNA-based vaccines against hantaviruses. ・Bloomberg reported on Friday that Moderna’s hantavirus research is ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...

The biotech company a pre-clinical program with the U.S. Army and a vaccine center at a Korean university.

Shares of Moderna ( MRNA) were up nearly 7% in recent trading, following a 12% jump Friday, after Bloomberg reported the ...